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Type II dehydroquinase is a small (150-amino-acid) protein
which in solution packs together to form a dodecamer with 23
cubic symmetry. In crystals of this protein the symmetry of the
biological unit can be coincident with the crystallographic
symmetry, giving rise to cubic crystal forms with a single
monomer in the asymmetric unit. In crystals where this is not
the case, multiple copies of the monomer are present, giving
rise to signiﬁcant and often confusing noncrystallographic
symmetry in low-symmetry crystal systems. These different
crystal forms pose a variety of challenges for solution by
molecular replacement. Three examples of structure solutions,
including a highly unusual triclinic crystal form with 16
dodecamers (192 monomers) in the unit cell, are described.
Four commonly used molecular-replacement packages are
assessed against two of these examples, one of high symmetry
and the other of low symmetry; this study highlights how
program performance can vary signiﬁcantly depending on the
given problem. In addition, the ﬁnal reﬁned structure of the
16-dodecamer triclinic crystal form is analysed and shown not
to be a superlattice structure, but rather an F-centred cubic
crystal with frustrated crystallographic symmetry.
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1. Introduction
Molecular replacement where multiple molecules are
searched for is not unusual owing to the frequency of non-
crystallographic symmetry in protein crystal structures
(Kleywegt, 1996; Vonrhein & Schulz, 1999). Many-body
searches in molecular replacement are usually carried out
sequentially: an individual copy of the molecule is located, its
contribution is ﬁxed and the next molecule is then searched
for (Navaza, 1994). Each step is dependent on the information
gained in the previous rotation and translation searches;
therefore, if many molecules are to be found, the accuracy of
the initial solutions is critical for success. Crystal structures
containing many molecules can prove to be difﬁcult
molecular-replacement problems. In part, this is a conse-
quence of the fraction of the total scattering contributed by
the individual search model being small and hence the signal
being searched for being weak. This problem will be exacer-
bated if the search model differs signiﬁcantly from the target
structure owing to low sequence similarity, disordered regions
and systematic deviations introduced by domain movements.
A solution to the weak signal being searched for is the
application of automated search procedures, which evaluate
many peaks in the rotation and translation searches; success
still relies on the ability to identify correct solutions via a given
scoring function. More recently, the introduction of maximum-
likelihood molecular-replacement functions have made asigniﬁcant impact on this problem (McCoy, 2007). A number
of solutions to the problem of many molecules have been
proposed; for example, when the macromolecular assembly of
the protein is known with simple point-group symmetry then a
locked rotation function can be used (Tong & Rossmann,
1990). Some molecular-replacement procedures attempt to
locate many bodies through simultaneous multi-dimensional
searches (Kissinger et al., 1999; Glykos & Kokkinidis, 2000),
while a method permitting the construction of a multi-copy
search model from properly oriented monomers using a
special translation function has also been proposed (Vagin &
Teplyakov, 2000). In cases where there is signiﬁcant transla-
tional symmetry, which can be identiﬁed from strong peaks in
the Patterson function of the X-ray data, a subset of the data
can be considered, reducing the number of independent
bodies to be located and signiﬁcantly reducing the computa-
tional time (Navaza et al., 1998). Overall, these methods have
allowed the solution of complex multiple-copy problems such
as 15 copies of the aggregation-prone V  antibody ﬁbre
(McCoy, 2007), 16 copies of the ribonuclease inhibitor barstar
(Navaza et al., 1998) and 24 copies of superoxide dismutase
with twinning (Lee et al., 2003).
In this paper, we will consider a number of structures of
type II dehydroquinase (DHQase), which catalyses the
dehydration of dehydroquinate to dehydroshikimate, the third
step in the shikimate pathway. The importance of the shiki-
mate pathway for the synthesis of aromatic compounds in
microorganisms and its absence in animals make the enzymes
attractive targets for the development of antimicrobials
(Abell, 1999). Type II DHQase is a small ( 150 amino-acid
residue) protein with a ﬂavodoxin-like fold and a dodecameric
quaternary structure in which the monomers are related by
cubic 23 symmetry (Fig. 1). The structure has been solved in a
number of different crystal forms, including a single monomer
in the asymmetric unit of Mycobacterium tuberculosis
DHQase in the cubic space group F23 (Gourley et al., 1999), a
dodecamer of the Streptomyces coelicolor enzyme in space
groups P212121 and P21 (Roszak et al., 2002) and the related
protein from Bacillus subtilis in space group P21 with two
dodecamers (24 monomers) in the asymmetric unit (Robinson
et al., unpublished work). A transition-state analogue 2,3-
anhydroquinate (Ki =3 0mM), designed to mimic the ﬂattened
enolate intermediate, provided a starting inhibitor for struc-
ture-based drug design. The crystal structure of this inhibitor
with the S. coelicolor enzyme (Roszak et al., 2002) not only
identiﬁed the binding mode of the substrate but also showed
glycerol and tartrate molecules (derived from the crystal-
lization mother liquor) in close proximity. These additional
ligand-binding sites have been the focus of inhibitor design by
several groups (Sanchez-Sixto et al., 2005; Toscano et al., 2003;
Payne et al., 2007; Prazeres et al., 2007), which has resulted in
the structure-based design of nanomolar inhibitors. The high-
resolution structure determination of DHQase–inhibitor
complexes is critical for the understanding of ligand binding
and to identify new directions for inhibitor design. New crystal
forms are encountered if cocrystallization of inhibitors is
performed; in addition, new crystallization conditions must be
found for enzymes from different species. These provide
interesting and sometimes challenging cases for structure
solution by molecular replacement. Several cases involving
type II DHQase will be discussed here, including a large P1
structure containing 16 dodecamers in the asymmetric unit.
2. Molecular-replacement problems
2.1. Helicobacter pylori DHQase–AH9095 complex: a high-
symmetry example
The crystal structure of H. pylori DHQase with inhibitor
AH9095 (Robinson et al., 2006) proved to be a difﬁcult
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Figure 1
A ribbon representation (Carson, 1991) of the dodecamer structure of
type II DHQase from S. coelicolor viewed down the threefold axis (a) and
down a twofold axis (b). To the right of each dodecamer view is a ﬁve-
sphere tetrahedral-shaped model of the structure. A small central sphere
represents the centroid of the dodecamer; the four surrounding spheres
(which are joined to the centroid by lines) represent the position of the
threefold axes.molecular-replacement problem owing to the cubic symmetry
of the crystal and the low sequence identity with previously
solved DHQase structures. X-ray data were collected to 1.5 A ˚
resolution at the Daresbury SRS; the unit-cell parameters
were a = b = c = 131.4 A ˚ and the space group was F23. The
space group has 48 symmetry operators and from calculation
of the Matthews number (Tronrud et al., 1987) it seemed likely
that the asymmetric unit would contain a single DHQase
monomer, resulting in a solvent content of 50%. The available
DHQase structures which could be used as search models
were from M. tuberculosis, B. subtilis and S. coelicolor, which
had 33.5, 37.5 and 34.1% sequence identity, respectively, to
H. pylori DHQase.Various attempts at molecular replacement
using the three search models with the stand-alone version of
AMoRe (Navaza, 1994) were unsuccessful; the absence of a
strong single peak in the rotation function was a noticeable
feature of these attempts. From the known quaternary struc-
ture of the enzyme (Fig. 1), it can be seen that the monomer
makes extensive contacts within the dodecamer in addition to
any crystal contacts; therefore, the separation of self-vectors
and cross-vectors is poor in this case. In addition, the high
symmetry of the structure means that self-vectors from all the
molecules which are rotationally distinct in the unit cell (12 in
this case) are present, further confusing the data to be sear-
ched. The low sequence identity of the search model is also a
signiﬁcantproblem. The structure was eventually solved with a
polyalanine model of the M. tuberculosis enzyme (PDB code
2dhq) using the program EPMR (Kissinger et al., 1999), which
we have found to be useful for problematic molecular
replacements such as this.
2.2. H. pylori DHQase: the wrong space group
Crystallization trials of H. pylori DHQase mixed with a
ﬁvefold stoichiometric concentration of the non-substrate-like
inhibitor GR12160X resulted in crystals with hexagonal
bipyramid morphology in conditions containing 20%
1,4-butanediol, 0.1 M sodium acetate pH 4.5. The crystals
diffracted to 2.9 A ˚ resolution on beamline 9.6 at SRS Dares-
bury, where 60  of data were collected. Indexing the data with
DENZO (Otwinowski & Minor, 1997) indicated a rhombo-
hedral space group, with unit-cell parameters a = b = 182.9,
c = 658.8 A ˚ ,   = 120  (in the hexagonal setting). Scaling the
data with SCALEPACK (Otwinowski & Minor, 1997) showed
the space group to be R32, with an Rmerge of 10.2%, 99.4%
completeness and an average redundancy of 3.4. The
Matthews number was consistent with two dodecamers (24
monomers) in the asymmetric unit, so a dodecamer created
from the 1.5 A ˚ H. pylori DHQase–AH9095 inhibitor complex
structure should have made an excellent search model. All
attempts to solve this structure using AMoRe or EPMR gave
no hint of a solution, even when using a smaller search model
such as a trimer. Despite the sensible merging R-factor
statistics for data in R32, the data were reprocessed in lower
symmetry space groups (with no signiﬁcant improvement in
processing statistics) and molecular replacement was repeated
using the dodecamer as a search model. Using data processed
in C2 (65% complete), with unit-cell parameters a = 316.78,
b = 181.90, c = 243.66 A ˚ ,   = 115.67  and presumably six
dodecamers in the asymmetric unit (based on the Matthews
number), strong peaks were seen in the rotation function,
resulting in a good molecular-replacement solution for four
dodecamers using AMoRe with data between 12.0 and 4 A ˚
resolution. This solution gave an R factor of 41.7% and a
correlation coefﬁcient of 64.3% after rigid-body reﬁnement.
Analysis of the self-rotation function at this point highlighted
60  and 180  rotations coincident with the y axis at 50% of the
correlation expected for crystallographic symmetry, con-
ﬁrming the correct choice of space group. Reﬁnement using
REFMAC5 (Murshudov et al., 1996), all data to 2.9 A ˚ and tight
noncrystallographic symmetry (NCS) restraints (at dodecamer
level) gave an Rwork of 32.1%, an Rfree of 41.7% and a
correlation coefﬁcient of 76%. Inspection of the structure
using Coot (Emsley & Cowtan, 2004) revealed electron
density corresponding to a missing dodecamer which was
coincident with a crystallographic twofold axis of symmetry. A
model of half a dodecamer was produced and a rotation
followed by a phased translation search using weighted
difference map Fourier coefﬁcients from REFMAC5 was
performed with MOLREP (Vagin & Isupov, 2001). This
completed the structure solution, giving 4.5 dodecamers in the
asymmetric unit (54 monomers). Further reﬁnement with
REFMAC5 lowered Rwork to 29.3% and Rfree to 39.1%, with a
correlation coefﬁcient of 87.5%. Inspection of the structure
using Coot revealed electron density for two  -strands at
several crystal contacts between dodecamers; this density
arose from an ordered portion of the N-terminal polyhistidine
tag. No electron density consistent with the inhibitor
GR12160X was present in any of the 54 NCS-related active
sites and therefore in light of this and the incomplete data,
reﬁnement of the structure was not continued. This example
serves as a reminder that the presence of NCS in the structure
can confuse the interpretation of the correct space group and
in this case the crystal system.
2.3. S. coelicolor DHQase–CA1 complex: 192 molecules
As only approximately 1 mg of the CA1 bifunctional inhi-
bitor was available for cocrystallization with S. coelicolor
DHQase, extensive crystallization screening was not possible
in this case. Cocrystallizations were set up with an in-house
PEG/ion screen which had previously been successful in
producing a well diffracting orthorhombic crystal form of this
enzyme (Roszak et al., 2002). A dozen crystals were screened
for suitably high-resolution diffraction at the Daresbury SRS
as the crystal quality was variable and the crystals suffered
from anisotropic diffraction and high mosaicity (frequently
2 ). One of the crystals diffracted to 1.7 A ˚ resolution with low
mosaicity, allowing 250  of oscillation data to be collected.
Indexing the diffraction pattern with DENZO gave a large
I-centredtetragonalcellwithunit-cellparametersa=b=196.6,
c = 393.6 A ˚ ; however, the data did not merge with this
symmetry or as I-centred orthorhombic. Indexing the data in
lower symmetry such as C-centred monoclinic with unit-cell
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equally unsuccessful; however, the data were not mis-indexed
as they merged acceptably in space group P1. This large
triclinic crystal form had been encountered previously
(Roszak et al., 2002) and had been abandoned as being
impractical. In the absence of any other more amenable
crystals of this DHQase–inhibitor complex, a structure solu-
tion was attempted using these data. The data were processed
in P1 with unit-cell parameters a = 196.61, b = 196.49,
c = 240.62 A ˚ ,   =6 5 . 9 ,  = 65.9,   = 90.1  using the HKL suite
of programs dimensioned for viruses. The data were 93%
complete with 3 042 000 unique reﬂections to  1.7 A ˚ and an
average redundancy of 2.4. The merging R factor was 17%
owing to the low redundancy and the weakness of the data
beyond 2.0 A ˚ , which was a consequence of the data being
collected in one pass. Visual inspection of the merged
diffraction data with HKLVIEW (Collaborative Computa-
tional Project, Number 4, 1994) showed no pattern of alter-
nating strong and weak reﬂections as is observed in
superlattice structures where an inexact lattice translation has
resulted in a doubling of a cell dimension; instead, a curious
striped pattern involving blocks of data was seen (Fig. 2).
Analysis of the self-rotation function showed three perpen-
dicular twofold axes, in addition to other threefold and four-
fold rotations at a maximum of 83% of that expected for
crystallographic symmetry. The native Patterson map showed
a peak half the size of the origin at 0.127, 0.126, 0.240, indi-
cating translational NCS. A Matthews coefﬁcient of
2.4 A ˚ 3 Da
 1 can be derived for 16 dodecamers in the unit cell;
this assumes 50% solvent content for this crystal form as is
found in other S. coelicolor DHQase structures. Given such a
large number of molecules in the P1 cell, it was presumed that
the structure was a superlattice structure of some type. A
search of the Protein Data Bank (PDB; Sussman et al., 1998)
based on the size of the asymmetric unit (Fig. 3) reveals that
this structure is not unique in its size, as structures with a
complete virus as the asymmetric unit have been solved.
However, for its resolution, this structure is a signiﬁcant
outlier some 4–5 times larger in size than anything previously
deposited at this or higher resolution.
Molecular replacement was attempted using the stand-
alone version of AMoRe with a single dodecamer of the
S. coelicolor DHQase (PDB code 1gu1) as the search model,
data from 12.0 to 4.0 A ˚ resolution and a 25 A ˚ centre-of-mass
exclusion between solutions. Contrary to our expectations, the
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Table 1
Results of 16-body molecular replacement of the S. coelicolor DHQase–
CA1 inhibitor complex from AMoRe.
Euler angles ( )
Translations
(fractional coordinates)
’  xyzCC
R
factor
Translation
rank by CC
286.6 86.8 119.3 0 0 0 15.9 59.1
2.4 106.6 30.2 0.8775 0.8705 0.7577 28.7 57.0 1st
286.6 86.8 119.3 0.1273 0.1204 0.2416 31.4 57.7 4th
286.6 86.8 119.3 0.7332 0.2493 0.5002 34.3 57.4 7th
163.5 93.1 299.8 0.7422 0.7484 0.5004 36.9 55.0 7th
163.5 93.1 299.8 0.6118 0.6234 0.258 40.0 54.0 7th
16.2 87 119.6 0.9881 0.4972 0.9983 42.1 52.8 7th
182.4 106 29.8 0.6084 0.1232 0.2593 45.1 51.9 5th
16.2 87 119.6 0.8626 0.3741 0.7565 47.8 51.1 1st
16.2 87 119.6 0.2323 0.2573 0.4996 49.5 50.5 =1st
196.2 86.1 119.5 0.5015 0.0075 0.9993 52.0 49.6 1st
106.5 86.2 118.1 0.2395 0.7564 0.4983 53.8 48.8 =1st
73.9 93.4 298.1 0.489 0.5085 0.9992 55.4 48.1 =2nd
73.9 93.4 298.1 0.3634 0.3843 0.757 57.0 47.4 =1st
196.2 86.1 119.5 0.3719 0.8827 0.7559 58.6 46.9 =1st
106.5 86.2 118.1 0.1175 0.6313 0.2606 59.6 46.5 1st
After rigid-body reﬁnement 71.1 39.3
Figure 2
l = 0 section of X-ray data from the S. coelicolor DHQase–CA1 inhibitor
structure, illustrating the striped nature of strong and weak data in the
diffraction data.
Figure 3
A plot of asymmetric unit volume against resolution for the X-ray crystal
structures in the PDB. Entries with very small unit cells have been
omitted, as have structures determined at higher than 1.5 A ˚ resolution.
Four structures are represented by red stars as they do not ﬁt onto the
plot; namely (from left to right) entries 1wce (birnavirus, 234   10
6 A ˚ 3),
1w8x (bacteriophage Prd1, 192.5   10
6 A ˚ 3), 1ohg (Hk97 bacteriophage
capsid, 143   10
6 A ˚ 3) and 2btv (bluetongue virus core, 123   10
6 A ˚ 3). The
type II dehydroquinase structure reported here has an asymmetric unit
volume of 7.6   10
6 A ˚ 3 and is labelled 2bt4.16-body molecular replacement was both rapid and successful.
The rotation function gave only 24 signiﬁcant solutions and
from these each of the n-body translation solutions gave a
steady increase in correlation and decrease in R factor
(Table 1). The rigid-body reﬁnement of the ﬁnal six solutions
took twice as long as the molecular replacement itself and
resulted in a large increase in the correlation coefﬁcient and
decrease in the R factor consistent with a correct solution
(Table 1). The choice of packing function is critical to the
success of the molecular replacement, as the solutions chosen
for the third through to the eighth ﬁxed solution were not
ranked the best solutions as judged by the correlation coefﬁ-
cient. Analysis of the rigid-body reﬁnement of the solutions
showed that the third ﬁxed solution was the furthest away
from the correct position, needing a 4.1  rotation in   and 1 A ˚
translation in x. The other ﬁxed solutions were not changed by
rigid-body reﬁnement by more than a 1.0  rotation and a
translation of 0.5 A ˚ . The packing of the ﬁnal solution (Fig. 4)
was seen to be correct using RASMOL (Sayle & Milnerwhite,
1995) as the structure was too large to be viewed in a number
of other graphics viewers available at that time.
3. Comparison of molecular-replacement packages
The H. pylori DHQase–AH9095 complex and the S. coelicolor
DHQase–CA1 complex represent two extreme examples for
molecular replacement: that of high symmetry and multiple
copies, respectively. Four molecular-replacement packages
were assessed to compare their performances using these two
examples. The programs assessed were a recent stand-alone
version of AMoRe (Navaza, 1994), MOLREP v.9.4.09 (Vagin
& Teplyakov, 1997), EPMR v.3.1 (Kissinger et al., 1999) and
Phaser v.1.3.3 (McCoy et al., 2005). The four packages are
similar in that they are highly automated, requiring relatively
little user input. AMoRe, MOLREP and Phaser split the
molecular-replacement problem into a rotation and a trans-
lation search, but differ substantially in treatment of data and
their scoring of solutions. In contrast, EPMR is a six-
dimensional search program which uses a stochastic search
algorithm. This iteratively optimizes populations of trial
solutions, choosing the best trial solutions of one population to
generate a new population of solutions by introducing small
random variations in parameters. Current versions of the four
programs were used and calculations were performed on a
dual-processor 2.8 GHz Intel Xeon Unix workstation with
4 GB memory. As each program uses its own scoring function,
for consistency the coordinates of the output solutions were
reﬁned using REFMAC5 to generate an R factor and corre-
lation coefﬁcient for all data to 4.0 A ˚ . For the H. pylori
DHQase molecular replacement the complete protein model
of a 1.5 A ˚ structure of M. tuberculosis DHQase (PDB code
1h05) was used, while for the S. coelicolor DHQase case a
complete dodecamer of the S. coelicolor enzyme determined
at 1.8 A ˚ (PDB code 1gu1) was used. X-ray data were treated
with a high-resolution cutoff at 4.0 A ˚ , while depending on the
program used a low-resolution cutoff was applied at 15 A ˚ ,
12 A ˚ or not at all.
In this ﬁrst test case, the H. pylori DHQase–AH9095
complex, three programs successfully found a solution: Phaser
and MOLREP using all data to 4.0 A ˚ with default settings and
AMoRe using a 12 A ˚ low-resolution cutoff. In contrast, EPMR
did not ﬁnd a correct solution with several runs of the program
and an increased population size of up to 600 (Table 2). On
comparing the solutions found by Phaser, AMoRe and
MOLREP, it appears from the statistics that the MOLREP
solution is worse than those found by the other two programs.
MOLREP as implemented in CCP4 sets all B values to 20 A ˚ 2
and does not perform rigid-body reﬁnement of the ﬁnal
solutions as standard, which accounts for the difference.
Treating the solutions to ﬁve cycles of restrained reﬁnement
using REFMAC5 applied to all data to 2.0 A ˚ , the Phaser and
AMoRe solutions gave a comparable Rwork of 0.420 and an
Rfree of 0.485, while the MOLREP solution had an Rwork of
0.461 and an Rfree of 0.537; the resultant weighted Fourier
maps reﬂected this difference. In terms of computational time,
Phaser was 12 times faster than either AMoRE or MOLREP.
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Figure 4
Packing of the 16 dodecamers within the P1 unit cell of the S. coelicolor
DHQase–CA1 structure.
Table 2
Comparison of the performance of four common molecular-replacement
programs on two test cases of data.
AMoRe MOLREP EPMR Phaser
H. pylori DHQase (F23), Z0 =1
Correct solution Yes Yes No Yes
R factor/CC† 0.46/0.42 0.51/0.33 (0.48/0.38‡) 0.54/0.20 0.46/0.43
Computation time 54 min 1 h 13 min 23 min§ 4 min
S. coelicolor DHQase (P1), Z0 = 192
Correct solutions Yes (16) Yes (14) Yes (11) Yes (16)
R factor/CC† 0.37/0.77 0.55/0.51 (0.41/0.74‡) 0.51/0.54 0.33/0.88
Computation time 57 min 5 h 12 min 2 d 16 h§ 30 d 6 h
†A l lR factors and correlation coefﬁcients were calculated from output coordinates
using REFMAC5 for consistency. ‡ After six cycles of rigid-body reﬁnement using
REFMAC5 with data to 4 A ˚ . § Using all four processors of the computer.In the second test case (the S. coelicolor DHQase–CA1
complex), assessment of the programs is complicated by the
number of molecules to be found. A successful solution need
not ﬁnd all 16 dodecamers; if a sufﬁcient proportion of the
overall structure is correctly positioned then this can be
reﬁned and used to locate the rest of the structure, e.g. by
using a phased translation search as in the example in x2.2. In
this way, multi-copy structure solution is potentially easier
than the single-molecule case as it is tolerant to partial solu-
tions and it is possible to use averaging over multiple copies of
the protein to enhance the quality of the electron density to be
interpreted. To illustrate this point, Fig. 5 shows the effect of
two incorrectly positioned dodecamers in a related non-
isomorphous P1 S. coelicolor DHQase structure. The differ-
ence density is sufﬁciently unambiguous to identify that these
dodecamers are incorrect and to permit manual repositioning
of both molecules. Therefore, by this deﬁnition all four
programs were able to ﬁnd at least a partial solution to this
molecular-replacement problem. AMoRe and Phaser found all
16 copies of the search model, with the Phaser solution giving
better statistics than the AMoRe solution (Table 2). MOLREP
only found 14 dodecamers using data between 12 and 4 A ˚
resolution, while a run using all data to 4 A ˚ resulted in only
eight copies being located. The R factor and correlation
coefﬁcient for the 14-copy solution were far worse than those
from either AMoRe or Phaser. Ten cycles of rigid-body
reﬁnement with REFMAC5 using all data to 4.0 A ˚ resolution
improved the R factor and correlation coefﬁcient to accep-
table values, conﬁrming that the solution was of comparable
quality. Inspection of the resultant electron-density map
showed sufﬁcient positive difference density that the
remaining two dodecamers could be positioned with a phased
translation search. Finally, in the case of EPMR 16 copies of
the search model were found in the solution; however, ﬁve
dodecamers almost exactly overlapped existing solutions,
despite a bump radius of 25 A ˚ being applied. It is reasonable
to assume that if these overlapped copies had been avoided, a
more complete solution may have been obtained. Removal of
the ﬁve overlapping dodecamers followed by rigid-body
reﬁnement of the resultant 11 copies gave a value of 50% for
both the R factor and the correlation coefﬁcient. The electron-
density maps gave some indication that at least one of 11
dodecamers was incorrectly placed and some indication of the
missing ﬁve copies. This must therefore be considered as a
borderline molecular-replacement solution which would not
be proﬁtable to pursue. If we consider computation time as in
test case 1 (Table 2), AMoRE, with a solution in less than 1 h,
research papers
Acta Cryst. (2008). D64, 108–118 Stewart et al.   Type II dehydroquinase 113
Figure 6
(a) The active site of S. coelicolor DHQase with 16-fold averaged
weighted difference electron density corresponding to the inhibitor CA1
(the position of the unreﬁned model is shown in ball-and-stick
representation), clearly showing the stereochemistry of the bifunctional
inhibitor. Additional density corresponds to ordered water molecules in
the active site of the enzyme. (b) The ﬁnal unaveraged electron density
contoured at 2  for the active site of a representative monomer within the
structure.
Figure 5
Difference electron density (green, positive; red, negative) from a
molecular-replacement solution of a related P1 S. coelicolor DHQase
inhibitor complex showing one of two incorrectly positioned dodecamers.is ﬁve times faster than the partial solution obtained with
MOLREP (without considering the additional time required
for rigid-body reﬁnement). Phaser, whilst producing the most
accurate solution, is impractically slow in this test example.
In conclusion, the aim of this comparison was not to high-
light inadequacies of any of the four programs, but rather to
assess how well the various programs available perform on
two very different difﬁcult molecular-replacement problems.
From the results shown in Table 2, it can be seen that the
programs can take signiﬁcantly different amounts of time to
solve the same problem and do not all give the same quality of
solution.
4. Completing the S. coelicolor DHQase–CA1 complex
structure
The subsequent manipulation of the data set proved proble-
matic as the current PDB format is not compatible with 192
individually labelled chains. To circumvent this problem, each
dodecamer was given a unique chain identiﬁer A–P and the
monomers within it were numbered residues 1–150, 201–350,
401–550...2201–2350. This way, the structure could be reﬁned
using REFMAC5 with 16-fold averaging. The NCS operators
relating chain A to the other chains within the asymmetric unit
were calculated using LSQKAB (Collaborative Computa-
tional Project, Number 4, 1994) and a mask corresponding to
the position of chain A was created using NCSMASK
(Collaborative Computational Project, Number 4, 1994). The
program MAPROT (Collaborative Computational Project,
Number 4, 1994) was then used to superimpose the electron
density from each monomer onto chain A using the density
mask. Modiﬁcations to the model were initially performed
using X-AUTOFIT within QUANTA (Accelrys) on the chain
A dodecamer with 16-fold averaged 2Fo   Fc and Fo   Fc
maps. From the initial averaged difference map it was clear
that the inhibitor CA1 was present within the structure
(Fig. 6a). The ligand (CA1) was built and minimized using
INSIGHTII (Accelerys) and ﬁtted into the averaged Fo   Fc
density within the active sites of each monomer in dodecamer
A with QUANTA (Accelrys). Water molecules were added
manually using X-SOLVATE within QUANTA and auto-
matically in the later stages of reﬁnement using ARP (Lamzin
& Wilson, 1997). After two rounds of reﬁnement and model
building using averaged maps, model building proceeded for a
further three rounds using all the dodecamers and 16 chains of
water molecules using Coot. The ﬁnal model had an Rwork of
0.197 and an Rfree of 0.248 and comprises 216 514 protein
atoms, 28 394 water molecules and 6208 ligand atoms. 91.8%
of residues in the structure were in the most favoured regions
of the Ramachandran plot, with the remaining 8.2% in
allowed regions, while the molecular geometry was either as
good as or better than expected values as evaluated by
PROCHECK (Laskowski et al., 1993).
4.1. Overall packing
The symmetry of a crystal structure is normally reﬂected by
the symmetry of the X-ray data and is usually resolved at the
processing stage of the structure determination. The reﬁned
solution for the P1 structure indicates regular packing of
dodecamers within the unit cell, suggesting that there is a
higher symmetry present and that this higher symmetry is
somehow not exact and therefore noncrystallographic. If we
consider a single dodecamer, it is surrounded by eight other
dodecamers in what crudely approximates a body-centred
cubic structure with a unit cell with a ’ 98.3 A ˚ and Z =3 6
(three dodecamers). The threefold axes of the central dode-
camer are nearly coincident with the corners of the basic cube
structure as would be expected. However, the dodecamers at
the corners of this simple cell are not related by translation but
by a twofold rotation; therefore, the unit cell must be twice as
large, with a ’ 196.7 A ˚ and Z = 192 (16 dodecamers). The
relationship between the unit cell of the P1 structure and an
F-centred cubic cell is shown in Fig. 7, with the dodecamers
represented schematically for clarity.
It is easiest to consider the simplest F-centered cubic space
group, F23 (48 symmetry operators), which when applied to a
monomer in an idealized F-centred unit cell with a = 196.6 A ˚
generates dodecamers at each of the lattice points within the
cell (Fig. 8a, black molecules). To generate the remaining
dodecamers which are related by the twofold rotations, a
second monomer related to the ﬁrst by a twofold rotation
around (1/4, y, 0) or equivalent is required, making an open
network of molecules (Fig. 8a, red molecules). So far, this
accounts for half the molecules present in the unit cell (i.e. 96
monomers or eight dodecamers). If we consider the higher
symmetry space groups, it is possible to establish that F4132,
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Figure 7
The relationship between the P1 unit cell of the S. coelicolor DHQase
structure reported here (in black) and an idealized F-centred cubic lattice
with four unit cells shown in blue. The dodecamers in the P1 cell are
coloured uniquely and represented schematically by four atoms along the
four threefold axes connected to a central centroid atom (see Fig. 1).which has 96 symmetry operators if applied to the two inde-
pendent monomers, will generate all molecules in the actual
unit cell (Fig. 8b). Comparison with the actual crystal structure
superﬁcially shows a good agreement between the idealized
dodecamer positions and the true
dodecamer coordinates (Fig. 8c). This
rules out the NCS-related molecule
alone being responsible for frustrating
the true crystallographic symmetry by,
for example, the dodecamer symmetry
being 90  out of alignment with the
cubic symmetry. Instead, there are
relatively small deviations from ideal
positions which are at a maximum of
around 3.6 A ˚ (measured by eye).
That the symmetry of this pseudo-
cubic crystal structure is subtly broken
such that it can only be treated in P1
runs counter to our preconceptions
about molecules in the crystalline state.
To understand the cause of these
deviations, it is necessary to examine the
crystal contacts between dodecamers in
the crystal. Fortunately, these are very
limited and are dominated by the
interaction between dodecamers related
by the twofold rotation between NCS
monomers and seen in the F23
symmetry example (Fig. 8a). The crystal
contacts involve residues 42–48 from
helix  1 of the structure, which is rich in
alanine residues and makes a symme-
trical contact, with Ala45 packing
against Lys42 of the symmetry-related
dodecamer (Fig. 9). This small crystal
contact region does not involve any
hydrogen bonds and is dominated by
van der Waals interactions which
partially bury the two hydrophobic
surfaces. The amine N atom of Lys42 is
in proximity to the main-chain O atoms
of Ala45 and Ala46 so that a hydrogen
bond might be expected together with
an electrostatic interaction with the end
of the  -helix (residues 38–46). How-
ever, the conformation of this Lys42 in
almost all monomers suggests that no
signiﬁcant interaction is present and
that the amine interacts with solvent.
Thus, a pair of twofold crystal con-
tacts is formed at six equivalent sites on
the dodecamer, forming a network of
interactions extending  90  in each
direction and generating dodecamers
centred at all permutations of coordi-
nates with values 0 and 1/2 (Fig. 8a;
chains A, C, E, H, I, L, N and P). There
is sufﬁcient space within this F23 lattice
of dodecamers to pack one dodecamer
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Figure 8
(a) A stereoview of an idealized F-centred cubic unit cell, a = 196.6 A ˚ , with F23 crystallographic
symmetry (48 symmetry operators) applied to two schematic dodecamers coloured black and red.
This symmetry represents the basic arrangement of dodecamers in the P1 structure, with crystal
contacts formed at the twofold axes within the each dodecamer so that, for example, the central
dodecamer (red) forms crystal contacts with six other dodecamers (black) all at 90  from each other.
(b) The packing in (a) leaves space for four dodecamers within the unit cell, which form a second
lattice of dodecamers equivalent to the ﬁrst but involving a translation of (1/4, 1/4, 1/4) from the
origin. This arrangement is equivalent to F4132 crystallographic symmetry (96 symmetry operators),
which when applied to two monomers generates the entire 192 molecules found in the P1 crystal
structure. (c) A comparison of the 16 NCS dodecamers in the P1 structure (coloured uniquely) with
the idealized F4132 cubic structure as shown in (b). This highlights the general agreement between
the observed and idealized structures, while also illustrating the small differences in orientation in
individual dodecamers which break the higher symmetry.at the centre of a cube of eight dodecamers. These dodecamers
are deﬁned by the symmetry operators described by the higher
symmetry F4132. These dodecamers again form interactions at
the twofold axes, involving residues 42–48 from helix  1
forming a separate network of interactions, centred at all
permutations of coordinates with values 1/4 and 3/4 (Fig. 8b;
chains B, D, F, G, J, K, M and O).
The only questionremainingis how these equivalent lattices
interact with each other via crystal contacts. As the twofold
ends of the dodecamers are all involved in crystal contacts, the
accessible areas on the molecule that remain are around the
dodecamer threefold axes. The ﬁrst dodecamer view shown in
Fig.1 is down the threefold axis of the dodecamer, highlighting
the ﬂat compact nature of this region (represented by a sphere
in the schematic), while the reverse face of the dodecamer is
less suited to form crystal contacts owing to its open nature.
Crystal contacts are seen between the compact threefold
surfaces of the dodecamer (Fig. 9) and, not unexpectedly,
involve three equivalent contact points. Each contact point
involves residues from the N-terminus (residues 2–8), the end
of helix  2(residues 65–73) and part of strand  2 (residues 50–
54), with between six and 12 water molecules at each contact
point. The interactions are either hydrophilic or van der Waals
in nature, with several water-mediated hydrogen bonds (e.g.
Thr50 OG1 to Asn72 OD1, Glu68 OE2 to Glu68 OE2 and
Arg2 NH2 to Thr50 OG) and one direct hydrogen bond
between the side chain Arg2 NH1 and main chain Asn6 O.
From the interaction between dodecamers E and G (Fig. 9), it
can be seen that the threefold crystal contact is not symme-
trical but off-centre. Furthermore, if we consider that there are
only ﬁve of these threefold contacts within the unit cell rather
than potentially 32, the source of the breakdown in symmetry
becomes clearer. With reference to Fig. 8(b), if we compare
the environments of the idealized dodecamers formed by the
ﬁrst monomer (black) with those formed by the second NCS-
related monomer (red), the dodecamers formed by the ﬁrst
monomer can make threefold-to-threefold crystal contacts,
while those of the second monomer cannot. Therefore, only
eight of the dodecamers can be involved in the threefold
crystal contacts: four from each network of dodecamers
described in the previous paragraph, i.e. A, C, E and P at
positions 0 and 1/2 and G, J, K and M at positions 1/4 and 3/4.
Owing to the ubiquitous twofold interactions between dode-
camers involving the longest axis of the molecule, the
remaining space is too large for any one dodecamer to form
four symmetrical threefold interactions. In fact, only chains E
and M form three threefold interactions, one with each other
and two with two other dodecamers (E to M, E to G and E to
K, M to A and M to P). The space is sufﬁciently large that
dodecamers C and J make no threefold interactions, e.g.
between E and J (Fig. 9).
In conclusion, a combination of factors are responsible for
the breaking of the F4132 cubic symmetry in this case, namely
the predominant NCS twofold crystal contacts involving the
longest dimension of the dodecamer structure producing
slightly larger spaces which cannot be occupied symmetrically
by another dodecamer. It is tempting to
speculate that in the absence of any
threefold interactions, the crystal would
have F23 cubic symmetry with two
monomers in the asymmetric unit
(Fig. 8a). The presence of the threefold
interactions breaks the cubic symmetry
and distorts both networks of twofold
interactions. With relatively few three-
fold interactions (ﬁve out of a possible
16), any imperfections within the
packing of the crystal may result in
twinning or disordering of one of the
lattices, both of which have been
observed in the crystal form (unpub-
lished observations).
4.2. Multiple models compared
The reﬁned structure of the S. coeli-
color DHQase–CA1 inhibitor complex
results in 192 independent monomers
which can be structurally compared. At
1.7 A ˚ resolution, it is generally consid-
ered there are enough observations of
the parameters such that each monomer
can be considered independently. The
NCS-related molecules exist in chemi-
cally very similar but not identical
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Figure 9
Seven dodecamers from the S. coelicolor DHQase–CA1 structure represented as ribbons and
coloured by chain. This view of the structure illustrates the two types of crystal contacts seen within
the structure. The main interaction, which is made at each of the twofold axes of each dodecamer in
the structure, can be seen between chains F and G and between chains E and H and a perpendicular
view between chains B and F. With these interactions alone chains F, G, B and J (shown here)
together with chains D, K, M and O form a network of interactions. Chains E, H and I (shown here)
together with chains A, C, L,N and P form a similar network of interactions within the spaces left by
the ﬁrst group of dodecamers. The interactions made between these two groups of dodecamers are
via the ﬂat threefold face ofonly certain dodecamers.In this diagram the only interaction is between
chain E and G and is highlighted with three red stars roughly indicating the three interaction sites;
all other potential interactions are too distant, e.g. between chain E and chain J. This ﬁgure was
produced using PyMOL (DeLano, 2002).environments; therefore, 16-fold NCS restraints were applied
throughout the reﬁnement process, as applying a complete set
of NCS restraints was not possible with the current imple-
mentation of REFMAC5. It would be reasonable to expect
very similar values for the geometry of most monomers, while
individual chemical environments, for example at the three-
fold crystal contacts, could lead to some variations.
It is normal to consider the geometry of a protein structure
as a whole compared with ideal values derived from small-
molecule databases. However, in this case there are sufﬁcient
copies of the protein monomer that individual bond distances
and angles can be compared. Fig. 10 shows selected bond
distances and angles calculated for two of the three cysteine
residues in each monomer using PROCHECK. Each distance
and angle forms a Gaussian distribution of values centred on
the ideal value in most cases. This spread in values is some-
what surprising; however, it is unlikely that it represents true
variation between the structures within the crystal rather than
the coordinate error [Cruickshank DPI = 0.16 A ˚ (Cruick-
shank, 1999), 0.09 A ˚ maximum-likelihood (ML) positional
parameter, 5.6 A ˚ 2 ML thermal parameter (Murshudov &
Dodson, 1997)], which is a function of the resolution of the
data. The distributions of values do contain overall structural
information; for example, the distribution of the Cys40
CB—CA—C bond angles away from the ideal value. Effective
removal of the bond-distance and angle restraints while
maintaining 16-fold NCS results in a further broadening of the
distributions while the overall trend is preserved. The struc-
ture is interesting in the light of recent discussions regarding
the use of multiple models to more accurately describe either
the uncertainty or conformational heterogeneity of protein
X-ray structures (DePristo et al., 2004; Furnham et al., 2006).
However, here we have multiple copies of the same structure
ﬁtted to different regions of the electron density. The errors
associated with the X-ray data are hopefully nonsystematic
and therefore an enhancement in the signal-to-noise ratio and
hence the accuracy of the structure would be expected by
considering the ensemble of all 192 structures. Unfortunately,
the manipulation of so many NCS-related molecules and the
interpretation of the individual models is too laborious at this
time to make this a realistic proposition, given the current
tools available.
5. Summary
From crystallographic studies of the type II DHQase it is
apparent that the molecular symmetry of the quaternary
structure is rarely coincident with the crystallographic
symmetry. As a result 12, 24, 56 and 192 copies of the molecule
have needed to be found by molecular replacement, which
fortunately can be carried out with the biological unit of the
protein, the dodecamer, vastly simplifying the problem.
Molecular replacement with many copies can be problematic
when there is translational symmetry. Artiﬁcially high corre-
lation coefﬁcients for the ﬁrst molecule searched for are often
a symptom of this, as this molecule satisﬁes in part the
contributions of both the translationally related copies in the
structure (Navaza et al., 1998). There is no foolproof solution
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Figure 10
A comparison of speciﬁc bond angles and distances for all copies of two cysteine residues present in the S. coelicolor DHQase–CA1 structure using
PROCHECK (Laskowski et al., 1993). The solid and dashed lines represent the mean and standard deviation values as per Engh and Huber small-
molecule data.to counteract this problem, but identiﬁcation of the transla-
tional component in a self Patterson map may permit
searching for pairs of molecules or, if the translation results in
a doubling of the unit-cell axis, treating the data as if it was in a
smaller cell. If there is an indication of the frustrated
symmetry from the X-ray data then molecular replacement
can in some cases be carried out in the higher symmetry
despite poor merging R-factor statistics. In these cases, it is
hoped that generation of the full structure from this crystallo-
graphic symmetry and the application of rigid-body reﬁne-
ment will be sufﬁcient to produce a reasonable starting model.
Molecular replacement with many copies is not necessarily
problematic, as reﬁnement with NCS and the use of averaged
electron density means that a partial solution may be sufﬁcient
to solve the structure. However, not all molecular-replacement
packages handle multiple models well and, as is shown here,
the time taken to obtain a solution can be a signiﬁcant issue.
Therefore, when considering choices about the search model
and the resolution range of the X-ray data to use it is also
important to think carefully about the choice of molecular-
replacement program.
The large P1 S. coelicolor DHQase–CA1 inhibitor complex
described here with so many copies in the asymmetric unit is
an oddity which we have shown represents an extreme
example of frustrated F4132 symmetry. It is highly likely that
other examples of structures such as this have been encoun-
tered in the past and have been discarded as intractable owing
to their size. The P1 S. coelicolor DHQase–CA1 inhibitor
complex proves that problems such as this are tractable, if at
the limit of current molecular-replacement methods, and that
useful information can be extracted from these structures.
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